SCOPUS 정보 검색 플랫폼

Thrombosis Research

Volumn 135, Issue 1, 2015, Pages 205-207

First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia

(3) Ng, H J a Than, H a Teo, E C Y a

a SINGAPORE GENERAL HOSPITAL (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; RIFAMPICIN; RIVAROXABAN; SILVER; WARFARIN; BLOOD CLOTTING FACTOR 10A INHIBITOR; HEPARIN ANTAGONIST; MORPHOLINE DERIVATIVE; THIOPHENE DERIVATIVE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; BYPASS SURGERY; CASE REPORT; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; DRUG DOSE TITRATION; DRUG WITHDRAWAL; EMBOLECTOMY; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS; HEPARIN INDUCED THROMBOCYTOPENIA; HEPARINIZATION; HOSPITAL ADMISSION; HUMAN; IMMUNOASSAY; INTENSIVE CARE UNIT; INTERNAL JUGULAR VEIN; LEG ISCHEMIA; LETTER; LIMB SWELLING; LUNG EMBOLISM; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; OFF LABEL DRUG USE; OPTICAL DENSITY; PARTIAL THROMBOPLASTIN TIME; PERFUSION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTHROMBIN TIME; RESPIRATORY FAILURE; SEVERE RENAL IMPAIRMENT; THROMBOCYTE COUNT; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VEIN CATHETERIZATION; BLOOD CLOTTING; CHEMICALLY INDUCED; CHRONIC KIDNEY FAILURE; COMPLICATION; RENAL REPLACEMENT THERAPY; THROMBOCYTOPENIA; VEIN THROMBOSIS;

AGED; BLOOD COAGULATION; FACTOR XA INHIBITORS; FEMALE; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MORPHOLINES; PERIPHERAL VASCULAR DISEASES; PLATELET COUNT; RENAL DIALYSIS; THIOPHENES; THROMBOCYTOPENIA; VENOUS THROMBOSIS;

EID: 84922545326 PISSN: 00493848 EISSN: 18792472 Source Type: Journal
DOI: 10.1016/j.thromres.2014.06.005 Document Type: Letter

Times cited : (37)

References (7)

1
- 33747817651
- Heparin-Induced Thrombocytopenia
- G.M. Arepally, and T.L. Ortel Heparin-Induced Thrombocytopenia N Engl J Med 355 2006 809 817
- (2006) N Engl J Med , vol.355 , pp. 809-817
- Arepally, G.M.¹ Ortel, T.L.²

2
- 22144446420
- Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients
- A. Greinacher, B. Farner, H. Kroll, T. Kohlmann, T.E. Warkentin, and P. Eichler Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients Thromb Haemost 94 2005 132 135
- (2005) Thromb Haemost , vol.94 , pp. 132-135
- Greinacher, A.¹ Farner, B.² Kroll, H.³ Kohlmann, T.⁴ Warkentin, T.E.⁵ Eichler, P.⁶

3
- 84856792328
- Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis
- 9th ed. Chest
- L.A. Linkins, A.L. Dans, L.K. Moores, R. Bona, B.L. Davidson, and S. Schulman Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis American College of Chest Physicians Evidence-Based Clinical Practice Guidelines 9th ed. Chest 141 2012 e495S e530S
- (2012) American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , vol.141 , pp. e495S-e530S
- Linkins, L.A.¹ Dans, A.L.² Moores, L.K.³ Bona, R.⁴ Davidson, B.L.⁵ Schulman, S.⁶

4
- 45949112509
- Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays
- T.E. Warkentin, J.I. Sheppard, J.C. Moore, C.S. Sigouin, and J.G. Kelton Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays J Thromb Haemost 6 8 Aug 2008 1304 1312
- (2008) J Thromb Haemost , vol.6 , Issue.8 , pp. 1304-1312
- Warkentin, T.E.¹ Sheppard, J.I.² Moore, J.C.³ Sigouin, C.S.⁴ Kelton, J.G.⁵

5
- 84922491318
- Xarelto® 15 mg, 20 mg product information http://www.xarelto.com/html/downloads/2014-01-14-Xarelto-SPC-Nov2013-F2.pdf 2013
- (2013) Xarelto® 15 Mg, 20 Mg Product Information

6
- 0035953702
- Temporal aspects of heparin-induced thrombocytopenia
- T.E. Warkentin, and J.G. Kelton Temporal aspects of heparin-induced thrombocytopenia N Engl J Med 344 17 Apr 26 2001 1286 1292
- (2001) N Engl J Med , vol.344 , Issue.17 , pp. 1286-1292
- Warkentin, T.E.¹ Kelton, J.G.²

7
- 84910109400
- Design of the rivaroxaban for heparin-induced thrombocytopenia study
- L.A. Linkins, T.E. Warkentin, M. Pai, S. Shivakumar, R.A. Manji, and P.S. Wells Design of the rivaroxaban for heparin-induced thrombocytopenia study J Thromb Thrombolysis 38 4 2014 485 492
- (2014) J Thromb Thrombolysis , vol.38 , Issue.4 , pp. 485-492
- Linkins, L.A.¹ Warkentin, T.E.² Pai, M.³ Shivakumar, S.⁴ Manji, R.A.⁵ Wells, P.S.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.